Streetbeat News

Products Services

NVS

The FDA has approved Novartis' drug Kisqali for reducing the risk of recurrence in patients with HR+/HER2- early breast cancer. This approval could potentially boost Novartis' market position in the oncology sector.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:05 pm

TTWO

Speculation arises about a potential delay of Grand Theft Auto VI's release to 2026, despite Take-Two Interactive's confidence in a 2025 launch. Former Rockstar insider Obbe Vermeij suggests a decision on the release could be made by mid-2025, citing Rockstar's history of prioritizing quality over speed.

Portfolio Pulse from Franca Quarneti

September 17, 2024 | 5:04 pm

BLRX

BioLineRx Ltd. has launched 'Mobilization Matters', a digital resource for multiple myeloma patients preparing for stem cell collection. In partnership with the HealthTree Foundation, a patient survey is underway with data expected in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:03 pm

GOLD

Barrick Gold Corporation is projecting a 30% growth in gold-equivalent production by the end of the decade, focusing on organic growth from existing assets while exploring value-accretive opportunities.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:02 pm

BLKB

MSFT

Blackbaud and Microsoft are collaborating to integrate advanced cloud technology, AI, and analytics into nonprofit-focused software. This partnership aims to enhance the efficiency and impact of nonprofit organizations by leveraging Microsoft's AI and analytics within Blackbaud's donor management solutions.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:01 pm

CRWD

CrowdStrike has launched CrowdStrike Financial Services to offer tailored financing solutions for its AI-native Falcon platform. This initiative aims to simplify adoption and accelerate platform consolidation for clients.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 5:01 pm

APLD

BITF

BTBT

BTCM

BTDR

COIN

HIVE

HUT

IREN

RIOT

WULF

Crypto-linked companies' shares are rising as Bitcoin's price increases, driven by traders evaluating potential rate cuts.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 4:56 pm

NOW

ServiceNow (NYSE:NOW) has seen significant bullish options activity, with 17 notable trades indicating potential price movements between $400 and $900. Despite a slight current price dip, investor sentiment remains largely positive.

Portfolio Pulse from Benzinga Insights

September 17, 2024 | 4:46 pm

DDD

3D Systems shares rose following FDA clearance for its monolithic jetted denture solution, indicating potential growth in its healthcare segment.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 4:35 pm

CMND

SPRC

Clearmind Medicine Inc. has filed an international patent for a combination therapy involving Ibogaine and N-Acylethanolamines, developed in collaboration with SciSparc Ltd. This therapy aims to improve the safety and efficacy of Ibogaine-based treatments for substance use disorders. The patent represents a significant advancement in mental health and addiction treatment.

Portfolio Pulse from Juan Spínelli

September 17, 2024 | 4:31 pm